Expression and Clinical Significance of Serum miR-1247-3p in Ischemic Stroke
DOI:
https://doi.org/10.7546/CRABS.2023.07.15Keywords:
ischemic stroke, miR-1247-3p, biomarkers, serumAbstract
To investigate the expression and clinical significance of serum miR-1247-3p in patients with ischemic stroke, twenty-five patients with ischemic stroke were collected, and twenty-five healthy individuals were used as controls. RT-qPCR measured the expression of serum miR-1247-3p. Logistic regression analysis was applied to evaluate the effect of influencing factors, including miR-1247-3p, on ischemic stroke. Spearman analysis was applied to study the relationship between miR-1247-3p and clinicopathological characteristics. The sensitivity and specificity of serum miR-1247-3p in the diagnosis of ischemic stroke were evaluated by ROC curves. Results show that serum miR-1247-3p levels were significantly lower in patients with ischemic stroke than in controls (P < 0.001). miR-1247-3p expression levels negatively correlated with triglycerides (r = –0.425, P < 0.05). miR-1247-3p is a protective factor that can significantly influence the occurrence of ischemic stroke (OR, 0.401. 95% CI, 0.222–0.732; P = 0.002). miR-1247-3p had a sensitivity of 92% and a specificity of 88% for the diagnosis of ischemic stroke. We conclude that serum miR-1247-3p expression levels are significantly reduced in patients with ischemic stroke and could serve as a potential biological marker for diagnosing ischemic stroke.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Proceedings of the Bulgarian Academy of SciencesCopyright (c) 2022 Proceedings of the Bulgarian Academy of Sciences
Copyright is subject to the protection of the Bulgarian Copyright and Associated Rights Act. The copyright holder of all articles on this site is Proceedings of the Bulgarian Academy of Sciences. If you want to reuse any part of the content, please, contact us.